Corcept Therapeutics Incorporated (CORT) climbed 87 cents, or 6.2%, to close at $14.87 on 1.6 million shares traded Tuesday. The stock, which had run up sharply for a week after beating estimates and raising guidance in its August 1 earnings report, had given back part of that move in a falling wedge pattern, before popping out of that wedge on Tuesday. If price clears the lateral resistance level at $15.26, next targets for the biotech company are $16.50 and $18. Short interest of 10.6 times its average volume could fuel the move as shorts cover on a rally.

Health Insurance Innovations, Inc. (HIIQ) is also on the move. The stock rose 85 cents, or 2.5%, to $34.10 on Tuesday, after rallying by more than 5% on Monday, on no news. The stock, which rose sharply after its positive earnings announcement on August 2, flagged for about a week, but has now broken out of the flag, and is up more than 25% since its earnings report. Near-term targets are $35 and $38. In the longer term, this stock could run into the $45-$50 range.

MiMedx Group, Inc. (MDXG) reached a new all-time high of $17.24 before closing up 96 cents for the day at $16.74 on 4.4 million shares traded, nearly four times its average volume. While the company, which develops and markets regenerative biomaterial products and bioimplants, did not report news on Tuesday, price lifted out of a multi-month consolidation phase on the stock's largest trading volume this year. The near-term price target is $19 and long term targets are at $22 and $24. Unusual short interest of 23 times its average volume may fuel the move as shorts cover on a rally.

On the short side, Cummins Inc. (CMI) declined by 65 cents to close at $155.59 on 1.3 million shares traded Tuesday. The machinery stock reached an all-time high near $170 on July 31 -- the day before the company's disappointing earnings announcement on August 1 and subsequent slide down. That high appears to be a possible price reversal point, as the stock has dropped out of its rising price channel since then and has not been able to overcome the current resistance level in an attempted bounce-back. Next price targets are $150 and $144, and possibly much lower after that.

See Harry's video chart analysis on these stocks.

No holdings.

Good Trading!

Harry

For more of Harry Boxer, sign up for a FREE 7-Day Trial to his Real-Time Technical Trading Diary.

(c) 2017 AdviceTrade, Inc. All rights reserved. Distributed only by written permission of AdviceTrade and The Technical Trader at info@advicetrade.com . In using any portion of Harry Boxer's content, you agree to the terms and conditions governing the use of the service as described in our disclaimer at http://www.thetechtrader.com

Mr. Boxer's commentaries and index analysis represent his own opinions and should not be relied upon for purposes of effecting securities transactions or other investing strategies, nor should they be construed as an offer or solicitation of an offer to sell or buy any security. You should not interpret Mr. Boxer's opinions as constituting investment advice. Trades mentioned on the site are hypothetical, not actual, positions.

Harry Boxer Archive

Only logged in users are allowed to post comments. Register/ Log in

The Market Oracle is a FREE Financial Markets Forecasting & Analysis web-site.
(c) 2005-2024 MarketOracle.co.uk (Market Oracle Ltd) - Market Oracle Ltd asserts copyright on all articles authored by our editorial team and all comments posted. Any and all information provided within the web-site, is for general information purposes only and Market Oracle Ltd do not warrant the accuracy, timeliness or suitability of any information provided on this site. nor is or shall be deemed to constitute, financial or any other advice or recommendation by us. and are also not meant to be investment advice or solicitation or recommendation to establish market positions. We do not give investment advice and our comments are an expression of opinion only and should not be construed in any manner whatsoever as recommendations to enter into a market position either stock, option, futures contract, bonds, commodity or any other financial instrument at any time. We recommend that independent professional advice is obtained before you make any investment or trading decisions. By using this site you agree to this sites Terms of Use. From time to time we promote or endorse certain products / services that we believe are worthy of your time and attention. In return for that endorsement and only in the cases where you purchase directly though us may we be compensated by the producers of those products.